Overview
Study information
| Network: | HVTN |
| Grant Affiliation: | NA |
| Strategy: | NA |
| Study Type: | Phase Ib |
| Species: | Human |
| Stage: | Primary analysis complete |
| Study Start Date: | NA |
| Study Made Public: | NA |
Title
A Phase 1B open-label clinical trial to expand the characterization of the immune responses to the Merck Adenovirus serotype 5 HIV-1 gag/pol/nef vaccine in healthy, HIV-1 uninfected adult participants
Description
HVTN 071 is a Phase Ib open-label clinical trial to evaluate the safety and immunogenicity of the Merck Adenovirus serotype 5 HIV-1 gag/pol/nef vaccine, MRKAd5.
Sign in to see full information about this study and to download study data.
Products
Product info coming soon!Integrated data
No integrated data is available for this study.
Non-integrated data
No non-integrated data is available for this study.